BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
Yu Wu,1–5,* Huijuan Wang,1–4,* Jingtai Zhi,1–4,* Linfei Hu,1–4 Xiukun Hou,1–4 Xianhui Ruan,1–4 Xiangqian Zheng,1–4 Hui Liu,5 Ming Gao1–41Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute a...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-08-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/brms1-downregulation-is-a-poor-prognostic-biomarker-in-anaplastic-thyr-peer-reviewed-article-OTT |